CVS Group (LON:CVSG) Stock Keeps Hold Rating at Jefferies Financial Group

by · The Cerbat Gem

CVS Group (LON:CVSG – Get Free Report)‘s stock had its “hold” rating reiterated by stock analysts at Jefferies Financial Group in a report issued on Friday, Digital Look reports. They presently have a GBX 1,400 price target on the stock. Jefferies Financial Group’s price objective would suggest a potential upside of 11.66% from the stock’s previous close.

A number of other brokerages also recently commented on CVSG. Shore Capital Group reaffirmed a “hold” rating and set a GBX 1,400 price target on shares of CVS Group in a research report on Thursday. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a GBX 1,700 price objective on shares of CVS Group in a research report on Monday, July 27th. Finally, Berenberg Bank restated a “buy” rating and issued a GBX 2,000 price objective on shares of CVS Group in a research note on Thursday. Four research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of GBX 1,666.67.

Get Our Latest Research Report on CVS Group

CVS Group Trading Up 2.7%

Shares of CVSG stock opened at GBX 1,253.77 on Friday. The company has a debt-to-equity ratio of 92.34, a quick ratio of 0.90 and a current ratio of 1.07. The company has a market capitalization of £852.19 million, a price-to-earnings ratio of 18.20, a PEG ratio of 1.77 and a beta of 1.07. CVS Group has a 52-week low of GBX 1,062 and a 52-week high of GBX 1,648. The company has a 50-day simple moving average of GBX 1,288.61 and a two-hundred day simple moving average of GBX 1,229.58.

CVS Group (LON:CVSG – Get Free Report) last posted its earnings results on Thursday, September 24th. The company reported GBX 85.60 EPS for the quarter. CVS Group had a net margin of 2.31% and a return on equity of 5.35%. Research analysts anticipate that CVS Group will post 93.9393939 EPS for the current fiscal year.

Insider Transactions at CVS Group

In other news, insider Robin Alfonso acquired 768 shares of the company’s stock in a transaction that occurred on Thursday, August 6th. The shares were acquired at an average price of GBX 1,294 per share, for a total transaction of £9,937.92. Also, insider David Wilton acquired 1,500 shares of CVS Group stock in a transaction on Tuesday, August 4th. The shares were purchased at an average cost of GBX 1,276 per share, with a total value of £19,140. Insiders purchased a total of 3,860 shares of company stock worth $4,956,696 in the last quarter. Insiders own 1.48% of the company’s stock.

Key CVS Group News

Here are the key news stories impacting CVS Group this week:

  • Positive Sentiment: Dividend maintained: CVS Group recommended a final dividend for fiscal 2026, payable on December 4, 2026. The proposed payout supports shareholder returns and signals confidence in the company’s financial position. CVS Group recommends final dividend
  • Positive Sentiment: Insider buying: Non-executive director Laura Hagan purchased 4,128 CVS Group shares, a modest positive signal that may indicate management confidence in the company’s longer-term prospects. CVS Group director share purchase
  • Neutral Sentiment: Mixed analyst view: Berenberg reaffirmed its “buy” rating with a GBX 2,000 target, while Shore Capital maintained a “hold” rating with a GBX 1,400 target. The wide gap highlights differing views on CVS Group’s growth and valuation prospects.
  • Negative Sentiment: Annual results drew a negative market reaction: CVS Group reported quarterly EPS of GBX 85.60, a net margin of 2.31% and return on equity of 5.35%. Although the company remains profitable, these figures suggest limited margins, which may have disappointed investors after the full-year results. CVS Group full-year earnings results

About CVS Group

(Get Free Report)

CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business (“Animed Direct”).

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.

Read More